LA JOLLA PHARMACEUTICAL CO — Net Income by Fiscal Year
12 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/24bcc47b-ae23-4390-8c40-3f74a6f662dd/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2021 | $19.7M | 2021-01-01 – 2021-12-31 | evidence 0001564590-22-009182 |
| FY 2020 | $-39.4M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-011366 |
| FY 2019 | $-116.5M | 2019-01-01 – 2019-12-31 | evidence 0000920465-20-000036 |
| FY 2018 | $-62.1M | 2018-01-01 – 2018-12-31 | evidence 0000920465-20-000127 |
| FY 2017 | $-114.8M | 2017-01-01 – 2017-12-31 | evidence 0000920465-18-000007 |
| FY 2016 | $-78.2M | 2016-01-01 – 2016-12-31 | evidence 0000920465-17-000025 |
| FY 2015 | $-41.9M | 2015-01-01 – 2015-12-31 | evidence 0000920465-16-000106 |
| FY 2014 | $-21.3M | 2014-01-01 – 2014-12-31 | evidence 0000920465-15-000009 |
| FY 2013 | $-17.9M | 2013-01-01 – 2013-12-31 | evidence 0000920465-14-000021 |
| FY 2012 | $-7.7M | 2012-01-01 – 2012-12-31 | evidence 0001193125-13-136913 |
| FY 2011 | $-11.5M | 2011-01-01 – 2011-12-31 | evidence 0001193125-12-144016 |
| FY 2010 | $-3.8M | 2010-01-01 – 2010-12-31 | evidence 0001193125-12-144016 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
LA JOLLA PHARMACEUTICAL CO — all facts · Revenue · Operating Income